In smoker COPD patients, steroid treatment did not suppress these pathways, while a combination of steroid and STING inhibitor significantly reduced the expression of STING/IFN-β signaling and lowered the expression of remodeling markers. The gene discussed is IFNB1; the disease is chronic obstructive pulmonary disease.